Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

New Imaging Technology to Assess Effect of Enzyme Replacment Therapy on Eye Disease Progession in Mucopolysacchardiosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02583152
Recruitment Status : Recruiting
First Posted : October 22, 2015
Last Update Posted : November 28, 2017
Sponsor:
Collaborator:
BioMarin Pharmaceutical
Information provided by (Responsible Party):
Manchester Royal Eye Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : November 2020